PERTUSSIS RISK IN CHILDREN AS A FUNCTION OF TIME SINCE RECEIPT OF THE 5TH DOSE OF ACELLULAR PERTUSSIS VACCINE
ESPID Education. Klein N. Jun 10, 2011; 8088 Disclosure(s): Research grant from: Pfizer GSK Merck Sanofi Aventis Novartis
Nicola Klein
Nicola Klein

This content is available to ESPID members only


Click here for more information or if you are considering becoming an ESPID member.

Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies